These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Review article: new drug formulations, chemical entities and therapeutic approaches for the management of ulcerative colitis. Ng SC; Kamm MA Aliment Pharmacol Ther; 2008 Oct; 28(7):815-29. PubMed ID: 18627362 [TBL] [Abstract][Full Text] [Related]
6. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis. Andreoli A; Spinella S; Levenstein S; Prantera C Ital J Gastroenterol; 1994 Apr; 26(3):121-5. PubMed ID: 7914759 [TBL] [Abstract][Full Text] [Related]
12. Insight into the widespread problem of nonadherence to therapy in ulcerative colitis patients. Bernick SJ; Kane S Expert Rev Clin Immunol; 2010 Jul; 6(4):677-82. PubMed ID: 20594140 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study. Scherl EJ; Pruitt R; Gordon GL; Lamet M; Shaw A; Huang S; Mareya S; Forbes WP Am J Gastroenterol; 2009 Jun; 104(6):1452-9. PubMed ID: 19491859 [TBL] [Abstract][Full Text] [Related]
15. Which oral aminosalicylate for ulcerative colitis? Drug Ther Bull; 2011 Jan; 49(1):8-12. PubMed ID: 21220254 [TBL] [Abstract][Full Text] [Related]
16. New approaches to adherence issues when dosing oral aminosalicylates in ulcerative colitis. Tindall WN Am J Health Syst Pharm; 2009 Mar; 66(5):451-7. PubMed ID: 19233992 [TBL] [Abstract][Full Text] [Related]
17. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis. Baker DE; Kane S Rev Gastroenterol Disord; 2004; 4(2):86-91. PubMed ID: 15185719 [TBL] [Abstract][Full Text] [Related]
18. Colonic targeting of aminosalicylates for the treatment of ulcerative colitis. Klotz U Dig Liver Dis; 2005 Jun; 37(6):381-8. PubMed ID: 15893274 [TBL] [Abstract][Full Text] [Related]
19. Oral 5-ASA therapy in ulcerative colitis: what are the implications of the new formulations? Sandborn WJ J Clin Gastroenterol; 2008 Apr; 42(4):338-44. PubMed ID: 18277908 [TBL] [Abstract][Full Text] [Related]
20. Review article: 5-aminosalicylate formulations for the treatment of ulcerative colitis--methods of comparing release rates and delivery of 5-aminosalicylate to the colonic mucosa. Lichtenstein GR; Kamm MA Aliment Pharmacol Ther; 2008 Sep; 28(6):663-73. PubMed ID: 18532992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]